FSD PHARMA Aktie

 >FSD PHARMA Aktienkurs 
1.49 EUR    -2.1%    (Tradegate)
Ask: 1.55 EUR / 2000 Stück
Bid: 1.47 EUR / 2100 Stück
Tagesumsatz: 3833 Stück
Realtime Kurs von 8 bis 22 Uhr!
>FSD PHARMA Performance
1 Woche: -21,2%
1 Monat: -32,5%
3 Monate: -53,5%
6 Monate: -48,1%
1 Jahr: 0%
laufendes Jahr: 0%
>FSD PHARMA Aktie
Name:  FSD PHARMA B SUB. VTG
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA35954B2066 / A2PTUT
Symbol/ Ticker:  0K9A (Frankfurt) / HUGE (NASDAQ)
Kürzel:  FRA:0K9A, 0K9A.F, 0K9A:GR, NASDAQ:HUGE
Index:  -
Webseite:  https://fsdpharma.com/
Marktkapitalisierung:  24.1 Mio. EUR
Umsatz:  -
EBITDA:  -
Gewinn je Aktie:  -
Schulden:  -
Liquide Mittel:  -
Umsatz-/ Gewinnwachstum:  - / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  99.78 / 0.81 / -
Gewinnm./ Eigenkapitalr.:  - / -93.65%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Suchwörter:  FSD PHARMA
Letzte Datenerhebung:  23.10.20
>FSD PHARMA Eigentümer
Aktien: 14.84 Mio. St.
f.h. Aktien: 10.21 Mio. St.
Insider Eigner: 13.19%
Instit. Eigner: -
Leerverk. Aktien: -
>FSD PHARMA Peer Group

IMV
 
21.10.20 - 13:31
FSD Pharma Inc. Announces Closing of US$9.5 Million Registered Direct Offering (Business Wire EN)
 
TORONTO--(BUSINESS WIRE)-- #HUGE--FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced the closing of previously announced definitive agreements with investors for the purchase and sale of 4,318,179 Class B Subordin...
16.10.20 - 13:43
FSD Pharma suffers on $9.5M registered direct offering (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.10.20 - 15:25
FSD Pharma throws resources behind legacy anti-inflammatory drug as potential coronavirus therapy (Proactive Investors)
 
Focused solely on lead anti-inflammatory drug FSD-201 Plans Phase 2 study of drug known as micro PEA in October 2020 Raises some $40 million in financing to fund FSD-201 and other R&D initiatives What FSD Pharma does: FSD Pharma Inc (CSE:HUGE) (...
05.10.20 - 14:58
FSD Pharma launches mid-stage study of FSD201 in COVID-19; shares up 7% (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.09.20 - 16:13
NA Proactive news snapshot: Loop Insights, GR Silver Mining, FSD Pharma, BevCanna Enterprises ... (Proactive Investors)
 
Loop Insights Inc (CVE:MTRX) (OCTMKTS:VRZPF) said it has signed an agreement to grant Austin-based start-up CasaPerks a non-exclusive license to use various aspects of its technology in return for $1.93 million in a combination of cash and shares. In...
28.09.20 - 15:19
FSD Pharma wins FDA nod to begin Phase 2 clinical trial for its lead drug micro-PEA to treat coronavirus patients (Proactive Investors)
 
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) announced on Monday that the US Food and Drug Administration (FDA) has authorized the initiation of a Phase 2 study for the use of its lead candidate FSD-201, or anti-inflammatory ultra-micronized...
28.09.20 - 11:58
FSD Pharma higher on FDA approval of phase 2 clinical trial of FSD201 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
31.08.20 - 15:50
NA Proactive news snapshot: FSD Pharma, NexTech AR Solutions, Vox Royalty, Todos Medical ... (Proactive Investors)
 
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) announced on Monday that it has submitted an Investigational New Drug Application (IND) application to the US Food and Drug Administration (FDA) for the use of its lead candidate FSD-201, or anti-...
31.08.20 - 15:36
Thinking about buying stock in Aimmune Therapeutics, FSD Pharma, Amarin Corp, Trevena Inc, or American Airlines? (PR Newswire)
 
NEW YORK , Aug. 31, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AIMT, HUGE, AMRN, TRVN, and AAL....
31.08.20 - 13:55
FSD Pharma files Phase 2 clinical trial IND with the FDA for its lead candidate micro-PEA to treat coronavirus patients (Proactive Investors)
 
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) announced on Monday that it has submitted an Investigational New Drug Application (IND) application to the US Food and Drug Administration (FDA) for the use of its lead candidate FSD-201, or anti-...
31.08.20 - 13:02
FSD Pharma seeks FDA nod for FSD201 phase 2 trial in Covid-19 patients (PBR)
 
In this connection, the Canadian pharma company has submitted an investigational new drug (IND) application for FSD201 with the US regulator. The phase 2 trial will be a The post FSD Pharma seeks FDA nod for FSD201 phase 2 trial in Covid-19 patients...
31.08.20 - 09:07
FSD Pharma files IND for FSD201 to treat COVID-19 patients (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.08.20 - 00:04
FSD Pharma reports Q2 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.08.20 - 23:49
FSD Pharma Reports Second Quarter 2020 Financial Results (Business Wire EN)
 
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today reported that management's discussion and analysis of financial condition and results of operations (“MD&...
06.08.20 - 23:04
FSD Pharma Inc. Announces Closing of US$10 Million Registered Direct Offering to Institutional Investors (Business Wire EN)
 
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) announces the closing of a previously announced agreement with investors for the purchase and sale of 2,762,430 Class B Subordina...
31.07.20 - 22:55
FSD Pharma Inc., Developing its PEA Compound to Treat COVID-19, CEO Clip Video (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) CEO and Chairman, Raza Bokhari speaks about the company's lead Compound, PEA, to treat COVID-19.If you cannot view the video above, please...
31.07.20 - 18:12
NA Proactive news snapshot: Karora Resources, FSD Pharma, Esports Entertainment, Black Iron, Newrange Gold UPDATE … (Proactive Investors)
 
Karora Resources Inc (TSE:KRR), formerly known as RNC Minerals Corp (TSE:RNX), announced that a previously announced share consolidation was effective as the markets opened on Friday, and that it had partially monetized its Orford Mining position for...
31.07.20 - 16:48
FSD Pharma announces US$10 million registered direct offering as it advances FSD201 as possible COVID-19 treatment (Proactive Investors)
 
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE.CN) announced Friday it has launched a US$10 million registered direct offering.  The offering comes as the Canadian company actively works to submit an Investigational New Drug Application to the US Food and...
31.07.20 - 15:46
FSD Pharma slips 7% on equity offering (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
31.07.20 - 15:25
FSD Pharma under pressure on $10M registered direct offering (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Zitat des Tages: Frau Venus, meine schöne Frau, // Von süßem Wein und Küssen, // Ist meine Seele geworden krank; // Ich schmachte nach Bitternissen. - Heinrich Heine
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter

Copyright @ Boersentreff.de - Die Märkte im Blick!